In response to the Texas Stock Epinephrine Advisory Committee’s meeting on implementation of Senate Bill 294, a new state law that will allow schools in Texas to expand access to emergency asthma medications, Charlie Gagen, Director of Advocacy for the American Lung Association in Texas issued the following statement.